[CRVS] QoQ Quarter Result on 31-Mar-2016 [#Q1]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
05-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- -5.10%
YoY- -231.78%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,086 -10,297 -8,645 -6,347 -6,039 -3,151 -20,232 -32.91%
Tax -184 0 0 0 17,600 0 0 -
NP -11,086 -10,297 -8,645 -6,347 -6,039 -3,151 -20,232 -32.91%
Tax Rate - - - - - - - -
Total Cost 11,086 10,297 8,645 6,347 6,039 3,151 20,232 -32.91%
Ratio Analysis
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 CAGR
EPS -0.55 -0.51 -0.43 -5.39 -0.68 -0.15 -0.99 -32.29%
EPS Diluted -0.55 -0.51 -0.43 -5.39 -0.68 -0.15 -0.99 -32.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.